ReviewFrontiers in cardiovascular medicine2021

Targeting the microRNA-34a as a Novel Therapeutic Strategy for Cardiovascular Diseases.

Cun-Cun Hua et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.